Fig. 1

Median weight at baseline and follow-up 12 months later among patients with systemic treatment. The analysis is stratified by methotrexate (n = 8) and dupilumab (n = 12). Follow-up at 12 months (n = 15), at 9 months (n = 2), at 6 months (n = 3) due to missing value at 12 months or short time of follow-up. The difference in weight between baseline and follow-up was significant among patients treated with dupilumab (p = 0.002) but not among patients treated with methotrexate (p = 0.161). P values calculated using Wilcoxon matched-pairs sign-rank tests